Synairgen plc (LON:SNG – Get Rating)'s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 14.55 ($0.18) and traded as low as GBX 12.02 ($0.15). Synairgen shares last traded at GBX 13.22 ($0.16), with a volume of 269,782 shares.
Synairgen Trading Down 5.4 %
The company has a market capitalization of £25.17 million, a PE ratio of -52.08 and a beta of -2.29. The company has a debt-to-equity ratio of 0.09, a current ratio of 6.35 and a quick ratio of 6.35. The firm's 50 day moving average is GBX 10.73 and its 200 day moving average is GBX 14.53.
Synairgen Company Profile
(Get Rating)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Featured Articles
- MarketBeat Week in Review – 4/17 – 4/21
- 2 Industrial Strength Dividend Stocks Melting Up
- Proctor & Gamble Is Going To Set A New High
- AutoNation's Plans are Keeping Analysts Around
- Netflix Increases Buybacks: Can It Complete A Reversal In 2023?
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.